First Trust Nasdaq Pharmaceuticals ETF (FTXH)

Key Metrics

TER 60.00% per year

Distribution policy Distributing

Fund size USD 29 M

Inception date September 20, 2016

Holdings 51

Fund currency USD

Fund domicile US

Provider First Trust

For full official fund details, factsheets, and holdings, visit ftportfolios.com (opens in new tab).

Historical Return

Last updated: Jun 15, 2026

1 Year +37.7% +1.2% Div

3 Years (avg.) +10.7% +1.2% Div

5 Years (avg.) +6.7% +1.2% Div

Risk & Analysis Metrics

Last updated: Jun 15, 2026

Volatility

16.33% 1 Year

16.04% 3 Years

16.13% 5 Years

19.01% 10 Years

Max Drawdown

-7.34% 1 Year

-20.52% 3 Years

-20.52% 5 Years

-32.11% 10 Years

Sharpe Ratio

1.58 1 Year

0.42 3 Years

0.21 5 Years

0.20 10 Years

Return Triangle (Heatmap)

Last updated: Jun 15, 2026

	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
2016	-10.3%	0.5%	-3.6%	2.1%	3.6%	4.0%	3.7%	2.8%	2.4%	4.2%
2017		12.6%	-0.1%	6.5%	7.4%	7.1%	6.2%	4.8%	4.1%	5.9%
2018			-11.4%	3.6%	5.7%	5.8%	5.0%	3.6%	2.9%	5.1%
2019				21.2%	15.4%	12.3%	9.6%	6.9%	5.6%	7.7%
2020					9.9%	8.1%	5.9%	3.6%	2.7%	5.6%
2021						6.2%	4.0%	1.6%	0.9%	4.8%
2022							1.8%	-0.7%	-0.8%	4.5%
2023								-3.1%	-2.0%	5.4%
2024									-1.0%	9.8%
2025										21.9%

Distributions

*by ETF Portfolio Weight Last updated: Jun 15, 2026

Profit Margin Distribution

< 0%

13%

1y 3y N/A N/A

0 - 5%

1y 3y N/A N/A

5 - 10%

10%

1y 3y N/A N/A

10 - 15%

16%

1y 3y N/A N/A

15 - 20%

11%

1y 3y N/A N/A

20 - 30%

23%

1y 3y N/A N/A

30 - 40%

16%

1y 3y N/A N/A

> 40%

1y 3y N/A N/A

P/E Ratio Distribution

< 0

13%

1y 3y N/A N/A

0 - 10

1y 3y N/A N/A

10 - 15

1y 3y N/A N/A

15 - 20

24%

1y 3y N/A N/A

20 - 25

10%

1y 3y N/A N/A

25 - 35

26%

1y 3y N/A N/A

35 - 50

10%

1y 3y N/A N/A

> 50

10%

1y 3y N/A N/A

Discounted Cash Flow

Weighted Average Undervaluation

N/A

Undervalued

> 60%

1y 3y N/A N/A

45 - 60%

1y 3y N/A N/A

30 - 45%

1y 3y N/A N/A

15 - 30%

1y 3y N/A N/A

Fair (±15%)

1y 3y N/A N/A

Overvalued

15 - 30%

1y 3y N/A N/A

30 - 45%

1y 3y N/A N/A

45 - 60%

1y 3y N/A N/A

> 60%

1y 3y N/A N/A

Market Cap Size Distribution

Micro Cap

0.6%

1y 3y N/A N/A

Small Cap

0.0%

1y 3y N/A N/A

Mid Cap

12.9%

1y 3y N/A N/A

Large Cap

57.9%

1y 3y N/A N/A

Mega Cap

28.6%

1y 3y N/A N/A

Micro: < $300M Small: $300M–$2B Mid: $2B–$10B Large: $10B–$200B Mega: > $200B

Average metrics of all companies in portfolio

Last updated: Jun 21, 2026

Market
Average

Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares.	$212B	-
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price.	1.46%	2.03%
Beta Indicates the relationship between the price performance of a share and the market.	0.52	-
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth.	32.83	28.29
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything	-61.09	-
Profitable Companies	86%	-
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued.	36.99	14.56
Price to Sales Ratio Market cap divided by the revenue in the most recent year.	6.09	8.28
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company	8.46	10.72

Market
Average

Enterprise Value to EBIT Enterprise Value divided by EBIT	8.15	21.15
Enterprise Value to Revenue Enterprise value divided by revenue	6.19	8.72
Total Debt to Enterprise Value Total debt divided by enterprise value	0.13	0.05
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary.	0.85	0.33
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability.	15.01%	-6.18%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago.	-29.2%	-117.9%
Return on Equity Equity divided by market cap.	27.80%	1.23%
Return on Assets Indicates a company's profitability in relation to its total assets.	7.88%	3.29%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits.	15.12%	3.31%

Sectors

Manufacturing	84.5%
Professional, Scientific, and Technical Services	7.9%
Wholesale Trade	3.5%
Finance and Insurance	3.4%
Other	0.6%

Countries

United States	95.6%
Ireland	3.7%
United Kingdom	0.5%
Other	0.2%
Other	0.0%

Limit holdings to companies in a single sector.

$0B >$1T

Ratio between share price and earnings per share. A low ratio could indicate undervaluation.

<0 >50

Ratio of dividends in the last 12 months to current share price.

0% 3%

Revenue increase compared to the same quarter one year ago.

0% 30%

Net income increase compared to the same quarter one year ago.

0% 30%

Profitability of the last quarter.

<-30% >30%

A higher ratio indicates a higher risk. The ratio is difficult to compare between industries.

<0 >3

Discounted cash flow valuation vs. current price. Positive = undervalued, negative = overvalued.

<-50% >+100%

Market Cap

P/E Ratio

Total Investment

Weight

Johnson & Johnson

JNJ - Manufacturing

Market Cap $549.78B

P/E Ratio 26.5

Dividends 2.3%

Total Investment $2.17M

Weight 7.45%

Loading details…

Bristol-Myers Squibb Co.

BMY - Manufacturing

Market Cap $110.27B

P/E Ratio 15.2

Dividends 4.6%

Total Investment $2.15M

Weight 7.36%

Loading details…

Merck & Co Inc

MRK - Manufacturing

Market Cap $281.24B

P/E Ratio 31.5

Dividends 3.0%

Total Investment $2.15M

Weight 7.36%

Loading details…

Abbvie Inc

ABBV - Manufacturing

Market Cap $382.74B

P/E Ratio 106.2

Dividends 3.1%

Total Investment $2.07M

Weight 7.10%

Loading details…

Lilly(Eli) & Co

LLY - Manufacturing

Market Cap $1.03T

P/E Ratio 38.9

Dividends 0.6%

Total Investment $1.93M

Weight 6.62%

Loading details…

Pfizer Inc.

PFE - Manufacturing

Market Cap $143.74B

P/E Ratio 19.2

Dividends 6.8%

Total Investment $1.12M

Weight 3.85%

Loading details…

Regeneron Pharmaceuticals, Inc.

REGN - Manufacturing

Market Cap $62.84B

P/E Ratio 14.3

Dividends 0.6%

Total Investment $1.09M

Weight 3.74%

Loading details…

Biogen Inc

BIIB - Manufacturing

Market Cap $29.02B

P/E Ratio 21.0

Dividends 0.0%

Total Investment $1.06M

Weight 3.62%

Loading details…

Gilead Sciences, Inc.

GILD - Manufacturing

Market Cap $153.66B

P/E Ratio 16.7

Dividends 2.6%

Total Investment $1.03M

Weight 3.54%

Loading details…

Cardinal Health, Inc.

CAH - Wholesale Trade

Market Cap $51.94B

P/E Ratio 33.8

Dividends 0.9%

Total Investment $1.02M

Weight 3.49%

Loading details…

AMGEN Inc.

AMGN - Manufacturing

Market Cap $182.21B

P/E Ratio 23.3

Dividends 2.9%

Total Investment $1M

Weight 3.43%

Loading details…

Viatris Inc

VTRS - Finance and Insurance

Market Cap $17.9B

P/E Ratio -59.9

Dividends 3.1%

Total Investment $999.59K

Weight 3.43%

Loading details…

Zoetis Inc - Ordinary Shares - Class A

ZTS - Manufacturing

Market Cap $33B

P/E Ratio 12.6

Dividends 2.6%

Total Investment $996.04K

Weight 3.41%

Loading details…

Vertex Pharmaceuticals, Inc.

VRTX - Manufacturing

Market Cap $114.63B

P/E Ratio 26.5

Dividends 0.0%

Total Investment $992.66K

Weight 3.40%

Loading details…

United Therapeutics Corp

UTHR - Manufacturing

Market Cap $22.78B

P/E Ratio 18.1

Dividends 0.0%

Total Investment $966.56K

Weight 3.31%

Loading details…

Incyte Corp.

INCY - Professional, Scientific, and Technical Services

Market Cap $19.62B

P/E Ratio 13.7

Dividends 0.0%

Total Investment $644.06K

Weight 2.21%

Loading details…

Jazz Pharmaceuticals plc

JAZZ - Manufacturing

Market Cap $14.11B

P/E Ratio 471.5

Dividends 0.0%

Total Investment $632.75K

Weight 2.17%

Loading details…

Illumina Inc

ILMN - Manufacturing

Market Cap $24.5B

P/E Ratio 29.0

Dividends 0.0%

Total Investment $450.76K

Weight 1.55%

Loading details…

Exelixis Inc

EXEL - Professional, Scientific, and Technical Services

Market Cap $13.05B

P/E Ratio 16.6

Dividends 0.0%

Total Investment $440.87K

Weight 1.51%

Loading details…

Medpace Holdings Inc

MEDP - Professional, Scientific, and Technical Services

Market Cap $13.14B

P/E Ratio 28.4

Dividends 0.0%

Total Investment $415.36K

Weight 1.42%

Loading details…

Key Metrics

Compare similar ETFs

Historical Return

Risk & Analysis Metrics

Volatility

Max Drawdown

Sharpe Ratio

Return Triangle (Heatmap)

Distributions

Profit Margin Distribution

P/E Ratio Distribution

Discounted Cash Flow

Market Cap Size Distribution

Portfolio Concentration

Latest News

IMAAVY® (nipocalimab-aahu) demonstrates durable hemoglobin response and rapid onset of effect in pivotal Phase 2/3 study in warm autoimmune hemolytic anemia (wAIHA), an autoantibody-driven disease with no FDA-approved therapies

I Would Rebuild My Portfolio With Just These 3 Stocks If I Lost Everything Tomorrow

The Portfolio That Gets You a Waterfront Condo in Miami Beach

Average metrics of all companies in portfolio

Sectors

Countries

Stock Screener

Johnson & Johnson

Johnson & Johnson

Bristol-Myers Squibb Co.

Bristol-Myers Squibb Co.

Merck & Co Inc

Merck & Co Inc

Abbvie Inc

Abbvie Inc

Lilly(Eli) & Co

Lilly(Eli) & Co

Pfizer Inc.

Pfizer Inc.

Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc.

Biogen Inc

Biogen Inc

Gilead Sciences, Inc.

Gilead Sciences, Inc.

Cardinal Health, Inc.

Cardinal Health, Inc.

AMGEN Inc.

AMGEN Inc.

Viatris Inc

Viatris Inc

Zoetis Inc - Ordinary Shares - Class A

Zoetis Inc - Ordinary Shares - Class A

Vertex Pharmaceuticals, Inc.

Vertex Pharmaceuticals, Inc.

United Therapeutics Corp

United Therapeutics Corp

Incyte Corp.

Incyte Corp.

Jazz Pharmaceuticals plc

Jazz Pharmaceuticals plc

Illumina Inc

Illumina Inc

Exelixis Inc

Exelixis Inc

Medpace Holdings Inc

Medpace Holdings Inc

Cookie Settings